1 / 5

Instrumenting the Healthcare Enterprise for Discovery Opening Remarks

This presentation focuses on the vision for personalized medicine and how electronic medical records (EMR) with clinical decision support can facilitate translational research, diagnostic discovery, drug development, and improved individualized medicine and disease management. It highlights the importance of integrating genomic and phenotypic data in a high-capacity IT repository.

brenee
Download Presentation

Instrumenting the Healthcare Enterprise for Discovery Opening Remarks

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Instrumenting the Healthcare Enterprise for DiscoveryOpening Remarks James Mongan, MD President and CEO Partners HealthCare April 11, 2008

  2. The Next Frontier in Medicine Partners has focused on providing a system of high quality, safe and efficient care through its High Performance Medicine initiative The next major advance in patient care will be personalized medicine

  3. A Vision for Personalized Medicine EMR with clinical decision support • Facilitated translational research leading to • Diagnostic discovery • Drug development Improved individualized medicine & pre / post symptomatic disease management Integrated genomic and phenotypic data repository Genomic research with high capacity IT

  4. Clinical and Research Questions • Research • Why do some patients with asthma respond to steroid treatment while others do not? • Why does a mutation in Huntington’s gene cause a lethal defect? • Why do some patients with diabetes have few complications even with “poor” control whereas others with good control have severe complications? • Clinical • Can I lower my cholesterol by diet alone of should I start on an anti-cholesterol drug now? • Will a third line anti-cancer drug be more effective as a first line drug with a patient with lung cancer?

  5. A Vision for Personalized Medicine EMR with clinical decision support • Facilitated translational research leading to • Diagnostic discovery • Drug development Improved individualized medicine & pre / post symptomatic disease management Integrated genomic and phenotypic data repository Genomic research with high capacity IT

More Related